T. N. Chase

2.2k total citations
54 papers, 1.7k citations indexed

About

T. N. Chase is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, T. N. Chase has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 8 papers in Psychiatry and Mental health. Recurrent topics in T. N. Chase's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (13 papers) and Genetic Neurodegenerative Diseases (7 papers). T. N. Chase is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (13 papers) and Genetic Neurodegenerative Diseases (7 papers). T. N. Chase collaborates with scholars based in United States, Italy and Canada. T. N. Chase's co-authors include M. Maral Mouradian, Pepijn van den Munckhof, Leonard Verhagen Metman, Paolo Del Dotto, John Y. Fang, Paul Fedio, Carol A. Tamminga, Daniele Bravi, John W. Roberts and Thomas L. Davis and has published in prestigious journals such as Journal of Neuroscience, American Journal of Psychiatry and Neurology.

In The Last Decade

T. N. Chase

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. N. Chase United States 22 959 861 302 282 254 54 1.7k
Avinoam Reches Israel 26 590 0.6× 661 0.8× 229 0.8× 233 0.8× 326 1.3× 76 1.7k
Paolo Del Dotto Italy 26 1.5k 1.6× 783 0.9× 267 0.9× 221 0.8× 254 1.0× 46 2.1k
Mikko Kuoppamäki Finland 26 784 0.8× 1.1k 1.2× 363 1.2× 528 1.9× 386 1.5× 52 2.0k
L. Rouquier France 15 545 0.6× 872 1.0× 332 1.1× 263 0.9× 433 1.7× 18 1.6k
J. Blin France 23 707 0.7× 780 0.9× 446 1.5× 376 1.3× 251 1.0× 36 1.8k
L. Lachenmayer Germany 23 487 0.5× 945 1.1× 147 0.5× 88 0.3× 516 2.0× 54 1.8k
Christopher Kenney United States 21 1.3k 1.4× 749 0.9× 187 0.6× 205 0.7× 275 1.1× 32 2.0k
Beatrice A. Summers United Kingdom 12 1.2k 1.3× 619 0.7× 1.2k 3.9× 424 1.5× 212 0.8× 13 2.5k
Emmanuelle Pourcher Canada 21 1.0k 1.1× 485 0.6× 243 0.8× 260 0.9× 208 0.8× 49 1.6k
Natalie Thomas United Kingdom 8 394 0.4× 434 0.5× 167 0.6× 258 0.9× 321 1.3× 10 1.2k

Countries citing papers authored by T. N. Chase

Since Specialization
Citations

This map shows the geographic impact of T. N. Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. N. Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. N. Chase more than expected).

Fields of papers citing papers by T. N. Chase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. N. Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. N. Chase. The network helps show where T. N. Chase may publish in the future.

Co-authorship network of co-authors of T. N. Chase

This figure shows the co-authorship network connecting the top 25 collaborators of T. N. Chase. A scholar is included among the top collaborators of T. N. Chase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. N. Chase. T. N. Chase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chase, T. N.. (1997). A Gene for Parkinson Disease. Archives of Neurology. 54(9). 1156–1157. 16 indexed citations
2.
Tedeschi, Gioacchino, Alessandro Bertolino, Nina Lundbom, et al.. (1996). Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology. 47(3). 696–704. 49 indexed citations
3.
Marı́n, Concepció, et al.. (1996). Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors. Psychopharmacology. 123(2). 215–221. 16 indexed citations
4.
Chase, T. N. & Carol A. Tamminga. (1995). Alzheimer's dementia. American Journal of Psychiatry. 152(8). 1110–1110. 1 indexed citations
5.
Bravi, Daniele, et al.. (1994). Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms. Annals of Neurology. 36(1). 27–31. 134 indexed citations
6.
Aj, Friedhoff, et al.. (1992). Tourette syndrome. Extending basic research to clinical care.. PubMed. 58. 341–62. 17 indexed citations
7.
Baronti, Fabio, et al.. (1992). Partial dopamine agonist therapy of levodopa‐induced dyskinesias. Neurology. 42(6). 1241–1241. 30 indexed citations
8.
Mohr, Erich, et al.. (1990). Subgroups in Alzheimer's disease: fact or fiction?. PubMed. 15(4). 203–6. 6 indexed citations
9.
Chase, T. N., et al.. (1990). Motor response complications with chronic levodopa therapy.. PubMed. 53. 377–81. 8 indexed citations
10.
Barone, Paolo, et al.. (1989). D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.. PubMed. 65(4). 337–41. 1 indexed citations
11.
Chase, T. N., Jorge L. Juncos, Carlo Serrati, Giovanni Fabbrini, & Giuseppe Bruno. (1987). Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations.. PubMed. 45. 477–80. 19 indexed citations
12.
Fabbrini, Giovanni, J. L. Juncos, M. Maral Mouradian, Carlo Serrati, & T. N. Chase. (1987). 3–0‐methyldopa and motor fluctuations in Parkinson's disease. Neurology. 37(5). 856–856. 31 indexed citations
13.
Chase, T. N., et al.. (1986). Structural and functional studies of Gilles de la Tourette syndrome.. PubMed. 142(11). 851–5. 80 indexed citations
14.
Barone, Paolo, et al.. (1986). D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.. PubMed. 9 Suppl 4. 128–30. 12 indexed citations
15.
Tamminga, Carol A., Raymon Durso, Paul Fedio, & T. N. Chase. (1982). Vasopressin studies in Alzheimer's disease. 18(1). 48–49. 26 indexed citations
16.
Nutt, John G., et al.. (1980). Treatment With Tryptophan of Levodopa-Associated Psychiatric Disturbances. Archives of Neurology. 37(3). 155–156. 21 indexed citations
17.
Chase, T. N. & Ira Shoulson. (1975). Dopaminergic mechanisms in patients with extrapyramidal disease.. PubMed. 9. 359–66. 18 indexed citations
18.
Chase, T. N.. (1974). Clinical studies of dopaminergic mechanisms.. PubMed. 12(0). 427–34. 5 indexed citations
19.
Chase, T. N.. (1974). Serotonergic mechanisms and extrapyramidal function in man.. PubMed. 5. 31–9. 18 indexed citations
20.
Chase, T. N., et al.. (1969). Effect of anticonvulsants on brain serotonin.. PubMed. 94. 236–8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026